Equillium Stock (NASDAQ:EQ), Trade Ideas

Equillium

Equillium Inc is a biotechnology developing therapies to treat severe autoimmune and inflammatory disorders. Its pipeline includes itolizumab, a first-in-class antibody targeting the CD6-ALCAM pathway which plays a key role in the modulation of effector T cells - currently in a Ph 3 study for patients with acute graft-versus-host disease and a Ph 1b study for patients with lupus nephritis. EQ101, a first-in-class cytokine inhibitor that selectively targets IL-2, IL-9, and IL-15 is Ph2-ready and expected to begin enrolling patients in an alopecia areata study in 2H 2022. EQ102, a cytokine inhibitor that selectively targets IL-15 and IL-21, is ready for clinical development and expected to begin enrolling patients in a Ph 1study including patients with celiac disease.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

AKBA

APCX

BCAN

CDLX

CEIX

CHEK

CISS

DADA

DERM

DNUT

EGOX

ETAO

GLUE

GOEV

GWAV

IPDN

IVVD

MESO

MRNO

NBSE

NGVC

NOVA

NUVB

OPGN

PRAX

QRTEB

RDDT

STOK

SXTP

TIVC

TSLA

VKTX

WPRT

Shares of  Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss.

Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share.

Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Price Target

Pre-Market Outlook

Analyst Ratings

ALVR

CTSH

HBAN

KRTX

PAYX

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Cognizant Technology Solutions To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Tuesday

Short Sellers

ADMP

AMSC

ARAV

BPTS

BRSH

CELZ

CHNR

CPOP

EBET

EVGO

HSDT

LTRY

NEON

RBOT

SDGR

TTOO

UPWK

Why EVgo Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket

Equillium Inc

Invesco Russell 1000 Equal Weight ETF

EQT AB

Equity Bancshares, Inc. Class A Common Stock

Equity Bancshares Inc

Mensa Mining Corp

Equity Commonwealth Common Shares of Beneficial Interest

Equity Commonwealth

Equity Commonwealth 6.50% Pfd Conv Shs Ser D

EQUITABLE FINCL CORP by Equitable Financial Corp.

Equitable Financial Corp

EQB Inc

Equitable Holdings Inc

Equitable Holdings, Inc. Depositary Shares

Equitable Holdings, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series C

EQUINITI GROUP PLC ADR by Equiniti Group PLC

Equinix Inc

ALPS Equal Sector Weight ETF

EQ Labs Inc

Simplify Exchange Traded Funds Simplify Market Neutral Equity Long/Short ETF

EQUITY METALS CORPORATION by Equity Metals Corporation

Equity Metals Corp

Equinor ASA

Eqonex Ltd

Equity Residential Common Shares of Beneficial Interest

Equity Residential

ProShares Equities for Rising Rates ETF

EQRX INC COM

EQRX INC WT EXP

Equus Total Return Inc

EQS Group AG

EQT Corp

Equal Trading Inc

EQM TECHS & ENERGY INC by EQM Technologies & Energy, Inc.

EQM Technologies & Energy Inc

EQUITECH INTL CORP by Equitech Int'l Corp.

Equitech International Corp

EQUITRANS MIDSTREAM PFD A by Equitrans Midstream Corporation

Equitrans Midstream Corp

ALTAMIRE GOLD CORP ORD by Altamira Gold Corp

Altamira Gold Corp

LAKE WINN RESOURCES CORP by Lake Winn Resources Corp

Lake Winn Resources Corp

Valued Advisers Trust Kovitz Core Equity ETF

QuadrantProtocol

EQUATORIAL ENERGIA S/ADR by Equatorial Energia S.A.

Equatorial Energia SA

IQ Engender Equality ETF

E-Qure Corp

Invesco S&P 100 Equal Weight ETF

Equinox Gold Corp

Equalizer - Ethereum

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>Trade Desk</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with TTD, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 15 uncommon options trades for Trade Desk.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 40% bullish and 53%, bearish.</p>
<p>Out of all of the special options we uncovered, 3 are puts, for a total amount of $126,380, and 12 are calls, for a total amount of $755,000.</p>
<h3>What's The Price Target?</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $75.0 to $105.0 for Trade Desk over the last 3 months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Trade Desk's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Trade Desk's whale trades within a strike price range from $75.0 to $105.0 in the last 30 days. </p>
<h3>Trade Desk Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714158949_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>TTD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$21.6</td>
<td>$21.45</td>
<td>$21.45</td>
<td>$82.50</td>
<td>$117.9K</td>
<td>2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>TTD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/26/24</td>
<td>$3.55</td>
<td>$3.0</td>
<td>$3.05</td>
<td>$82.00</td>
<td>$92.7K</td>
<td>1.6K</td>
<td style="text-align: right;">22</td>
</tr>
<tr>
<td>TTD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/26/24</td>
<td>$3.95</td>
<td>$3.25</td>
<td>$3.3</td>
<td>$82.00</td>
<td>$88.1K</td>
<td>1.6K</td>
<td style="text-align: right;">327</td>
</tr>
<tr>
<td>TTD</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>05/10/24</td>
<td>$3.9</td>
<td>$3.8</td>
<td>$3.85</td>
<td>$90.00</td>
<td>$77.0K</td>
<td>1.0K</td>
<td style="text-align: right;">696</td>
</tr>
<tr>
<td>TTD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/10/24</td>
<td>$3.8</td>
<td>$3.75</td>
<td>$3.8</td>
<td>$90.00</td>
<td>$75.6K</td>
<td>1.0K</td>
<td style="text-align: right;">495</td>
</tr>
</tbody>
</table>
</p>
<h3>About Trade Desk</h3>
<p>The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on different devices like computers, smartphones, and connected TVs. It utilizes data to optimize the performance of ad impressions purchased. The firm's platform is referred to as a demand-side platform in the digital ad industry. The firm generates its revenue from fees based on a percentage of what its clients spend on advertising.</p>
<p>Following our analysis of the options activities associated with Trade Desk, we pivot to a closer look at the company's own performance.</p>
<h3>Trade Desk's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 1,909,795, the TTD's price is up by 2.12%, now at $85.11. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 12 days.</li>
</ul>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Trade Desk options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Options

This Is What Whales Are Betting On Trade Desk

<p>Deep-pocketed investors have adopted a bullish approach towards Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in GILD usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Gilead Sciences. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 77% leaning bullish and 22% bearish. Among these notable options, 4 are puts, totaling $495,628, and 5 are calls, amounting to $213,111.</p>
<h3>Projected Price Targets</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $50.0 to $68.0 for Gilead Sciences during the past quarter. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Gilead Sciences's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Gilead Sciences's significant trades, within a strike price range of $50.0 to $68.0, over the past month.</p>
<h3>Gilead Sciences Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714158944_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>GILD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$10.5</td>
<td>$7.1</td>
<td>$9.2</td>
<td>$67.50</td>
<td>$367.9K</td>
<td>162</td>
<td>400</td>
</tr>
<tr>
<td>GILD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$3.0</td>
<td>$2.81</td>
<td>$2.81</td>
<td>$50.00</td>
<td>$70.2K</td>
<td>662</td>
<td>254</td>
</tr>
<tr>
<td>GILD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/21/24</td>
<td>$1.49</td>
<td>$1.43</td>
<td>$1.49</td>
<td>$67.50</td>
<td>$59.7K</td>
<td>405</td>
<td>556</td>
</tr>
<tr>
<td>GILD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$0.51</td>
<td>$0.46</td>
<td>$0.51</td>
<td>$68.00</td>
<td>$51.1K</td>
<td>2.2K</td>
<td>1.0K</td>
</tr>
<tr>
<td>GILD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/21/24</td>
<td>$2.63</td>
<td>$2.59</td>
<td>$2.62</td>
<td>$65.00</td>
<td>$36.5K</td>
<td>283</td>
<td>292</td>
</tr>
</tbody>
</table>
</p>
<h3>About Gilead Sciences</h3>
<p>Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.</p>
<p>After a thorough review of the options trading surrounding Gilead Sciences, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Gilead Sciences's Current Market Status</h3>
<ul>
<li>With a trading volume of 8,730,709, the price of GILD is up by 0.77%, reaching $65.78.</li>
<li>Current RSI values indicate that the stock is may be oversold.</li>
<li>Next earnings report is scheduled for 97 days from now.</li>
</ul>
<h3>What The Experts Say On Gilead Sciences</h3>
<p>5 market experts have recently issued ratings for this stock, with a consensus target price of $82.2.</p>
<ul>
<li>Maintaining their stance, an analyst from Oppenheimer continues to hold a Outperform rating for Gilead Sciences, targeting a price of $105. </li>
<li>Maintaining their stance, an analyst from Morgan Stanley continues to hold a Equal-Weight rating for Gilead Sciences, targeting a price of $78. </li>
<li>Consistent in their evaluation, an analyst from TD Cowen keeps a Buy rating on Gilead Sciences with a target price of $85. </li>
<li>Consistent in their evaluation, an analyst from RBC Capital keeps a Sector Perform rating on Gilead Sciences with a target price of $74. </li>
<li>An analyst from HSBC has elevated its stance to Hold, setting a new price target at $69. </li>
</ul>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Gilead Sciences with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


GILD

Gilead Sciences Unusual Options Activity

<p>Deep-pocketed investors have adopted a bearish approach towards Pinterest (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in PINS usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options activities for Pinterest. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 45% leaning bullish and 54% bearish. Among these notable options, 3 are puts, totaling $263,130, and 8 are calls, amounting to $428,002.</p>
<h3>What's The Price Target?</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $27.0 to $40.0 for Pinterest over the recent three months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Pinterest stands at 4200.0, with a total volume reaching 5,646.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Pinterest, situated within the strike price corridor from $27.0 to $40.0, throughout the last 30 days.</p>
<h3>Pinterest Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714158937_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>PINS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$5.5</td>
<td>$5.35</td>
<td>$5.45</td>
<td>$35.00</td>
<td>$152.0K</td>
<td>4.6K</td>
<td>279</td>
</tr>
<tr>
<td>PINS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/03/24</td>
<td>$1.4</td>
<td>$1.29</td>
<td>$1.37</td>
<td>$32.00</td>
<td>$123.0K</td>
<td>2.8K</td>
<td>2.6K</td>
</tr>
<tr>
<td>PINS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/17/24</td>
<td>$0.85</td>
<td>$0.83</td>
<td>$0.86</td>
<td>$30.00</td>
<td>$111.1K</td>
<td>10.8K</td>
<td>1.4K</td>
</tr>
<tr>
<td>PINS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$3.55</td>
<td>$3.5</td>
<td>$3.5</td>
<td>$40.00</td>
<td>$62.3K</td>
<td>13.0K</td>
<td>195</td>
</tr>
<tr>
<td>PINS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/19/24</td>
<td>$2.03</td>
<td>$1.97</td>
<td>$2.02</td>
<td>$37.00</td>
<td>$57.5K</td>
<td>936</td>
<td>301</td>
</tr>
</tbody>
</table>
</p>
<h3>About Pinterest</h3>
<p>Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from cooking recipes to travel destinations. Founded in 2010, the platform consists of a largely female audience, which accounts for roughly two thirds of its nearly 500 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features. About 20% of users reside in the US and Canada, but the region accounted for about 80% of revenue in 2023.</p>
<p>In light of the recent options history for Pinterest, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Where Is Pinterest Standing Right Now?</h3>
<ul>
<li>With a trading volume of 8,051,867, the price of PINS is up by 3.91%, reaching $33.91.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 4 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Pinterest</h3>
<p>In the last month, 1 experts released ratings on this stock with an average target price of $40.0.</p>
<ul>
<li>An analyst from Keybanc persists with their Overweight rating on Pinterest, maintaining a target price of $40. </li>
</ul>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Pinterest options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


PINS

Pinterest's Options: A Look at What the Big Money is Thinking

Stock Split

ATXI

Avenue Therapeutics shares are trading lower. The company recently announced a 1-for-75 reverse stock split of its common stock.

WIIM

SMXT

SolarMax Technology shares are trading higher. The stock may be rebounding after falling last week.

Legal

GOOG

GOOGL

Google Files Motion For Summary Judgment In U.S. Adtech Case Led By Justice Dept

<p><strong>Intel Corp</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) stock fell after reporting a first-quarter (Q1) revenue miss and weak <a href="https://www.benzinga.com/quote/INTC/guidance">Q2 EPS guidance</a>.</p>
<p>The company&#8217;s quarterly earnings of 18 cents per share beat the consensus estimate by 28.57%. However, sales of $12.72 billion missed estimates by 0.44%.</p>
<p><em>Related: <a href="https://www.benzinga.com/news/earnings/24/04/38444720/intel-shares-fall-on-q1-revenue-miss-weak-q2-eps-guidance">Intel Shares Fall On Q1 Revenue Miss, Weak Q2 EPS Guidance</a></em></p>
<p>CEO Pat Gelsinger remains confident in company&#8217;s future, proclaiming &#8220;Intel is back.&#8221;</p>
<p>Here's what analysts have to say about the earnings report.</p>
<ul>
<li>JPMorgan Chase analyst Harlan Sur reiterated Underweight on Intel stock, reducing the price target from $37 to $35 a share.</li>
<li>Goldman Sachs analyst Toshiya Hari maintains his Sell rating on the stock, reducing the price target from $39 to $34.</li>
<li>Oppenheimer analyst Rick Schafer maintained his Perform rating on the stock without stating a price target.</li>
<li>Needham analyst N. Quinn Bolton, CFA reiterated Hold with no price target on the stock.</li>
<li>Wedbush analyst Matt Bryson rates the stock Neutral with his 12-month price target on the stock down from $40 to $32.50 a share.</li>
<li>BofA Securities analyst Vivek Arya reiterated his Neutral rating on the stock, while lowering price target from $44 to $40.</li>
<li>Mizuho Securities analyst Vijay Rakesh rates the stock a Buy with price target lowered from $55 to $45 a share.</li>
</ul>
<p><em>Also Read: <a href="https://www.benzinga.com/news/24/04/38447614/intel-ceo-said-foundry-business-will-see-sequential-improvement-in-every-quarter-till-2030-conf-call">Intel CEO Said Foundry Business Will See Sequential Improvement In Every Quarter Till 2030- Conf Call</a></em></p>
<p><strong>JPMorgan</strong>: According to Sur, Intel&#8217;s guidance suggests a slow recovery for PC and data center segments, requiring a strong second half for full-year outlook. There appear to be confidence issues in core compute and diversification initiatives. </p>
<p>Customer foundry revenue was lower than expected in Q1, but product and technology pipeline remains strong. The company&#8217;s roadmap milestones are on track, with new products like Sierra Forest and Granite Rapids ramping up. Overall, while 2Q guidance is muted, there is optimism for a gradual recovery in general compute demand but Intel &#8220;<strong>will be an underperformer relative to the group</strong> over the next 12-18 months,&#8221; Sur says.</p>
<p><strong>Goldman Sachs</strong>: Intel&#8217;s 2Q24 revenue and non-GAAP EPS guidance were lower than expected, attributed to the delayed recovery in traditional server demand now expected in H2. This delay is due to Cloud and Enterprise customers prioritizing AI infrastructure spending. &#8220;AI prioritization continues to weigh on traditional server demand&#8221; said Hari.</p>
<p>Goldman Sachs remains &#8220;encouraged by Intel's progress in Accelerating Computing&#8221;, particularly with the launch of Gaudi3. However, it faces challenges in maintaining its share in the Data Center Compute market against competitors like <strong>Nvidia Corp </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and <strong>Arm Holdings PLC</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>).</p>
<p><strong>Oppenheimer</strong>: &#8220;We remain on sidelines as turnaround efforts take root,&#8221; said Schafer. He attributed Intel&#8217;s weaker Q1 performance to weaker demand and the sunsetting of non-core and traditional packaging. </p>
<p>Management sees Q1 as the bottom, expecting quarter-over-quarter growth throughout the year. PC and data center (DC) sales are expected to be flat in Q2, with DC leading in the second half due to the ramp of the Gaudi3 accelerator and cyclical recovery in other segments. </p>
<p>DC is expected to be up about 25% this year. Despite optimism, Intel&#8217;s roadmap and technology leadership are concerns for Schafer. While constructive on the data center outlook, caution remains regarding PC unit growth.</p>
<p><strong>Needham</strong>: Bolton&#8217;s Hold rating is due to Intel&#8217;s high valuation, declining revenue estimates, growing competition, and distant IFS revenue contributions, &#8220;all setting up for a <strong>more difficult road ahead</strong>&#8220;. </p>
<p>Intel faces challenges in the data center market, said Bolton, with wallet share shifting to AI-compute and competition from new architectures like ARM-based CPUs and evolving ASICs. While losses in Desktop and Notebook share have slowed, positive PC trends are insufficient to support INTC&#8217;s CY24 PC unit TAM.</p>
<p><strong>Wedbush</strong>: Intel Corp is &#8220;still a work in progress,&#8221; said Bryson. He notes that Intel&#8217;s guidance for >$500M in Habana sales in 2H&#8217;24 was below expectations, despite prior commentary suggesting a larger backlog and increased AI accelerator spending. </p>
<p>While Sierra Forrest and Granite Rapids are on track for release, Bryson sees their impact on Intel&#8217;s share and revenues being modest. Additionally, Meteor Lake experienced increased demand in CQ1, with units expected to double in CQ2, but supply constraints are hindering Intel&#8217;s ability to meet this demand as it ramps up wafer level assembly.</p>
<p>Wedbush also thinks &#8220;the recent pessimism weighing on the stock is arguably overdone.&#8221; But, analysts &#8220;still aren&#8217;t comfortable yet in getting more constructive around Intel.&#8221;</p>
<p><strong>BofA Securities</strong>: Arya noted &#8220;higher costs, lower growth, tough competition,&#8221; as three key attributes identifiable with Intel&#8217;s Q1 earnings report and future outlook.</p>
<p>Intel&#8217;s Q1 earnings met expectations, but Q2 guidance disappointed due to high costs. While Arya sees the company&#8217;s strong enterprise position and US manufacturing assets offering potential, limited AI exposure could hamper growth. Q2 sales missed targets amid weak macro demand. </p>
<p>However, Intel anticipates a strong second half driven by cyclical improvements, AI PC growth, and positive enterprise trends. The company is focusing on the Gaudi3 ramp, CHIPS grants, and cost reductions to improve profitability. Challenges include losing server market share and competition in AI accelerators. Arya sees Intel&#8217;s future success depending on leveraging manufacturing synergies and managing competition from <strong>Taiwan Semiconductor Manufacturing Co Ltd</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>).</p>
<p><strong>Mizuho Securities</strong>: &#8220;We remain positive on INTC given stable compute server share, Sierra Forest and Granite Rapids product ramps ahead, and valuation with low expectations,&#8221; said Rakesh.</p>
<p>According to Rakesh, Intel&#8217;s data-centric AI (DCAI) segment remains flat as the company plays catch-up with peers, with the Gaudi3 ramp in 2H expected to contribute but still at a small scale. </p>
<p>Intel&#8217;s data center (DC) is estimated to grow by 4% y/y in 2024, compared to Nvidia&#8217;s consensus estimate of 102% y/y growth. </p>
<p>Intel is ramping its foundry business, adding external customers and anticipating margins to trough in 2024 before a stronger ramp in 2025. Despite a disappointing June quarter guide, Rakesh believes new product ramps and stable server share, combined with low expectations, could limit downside as Intel trades at a lower P/S multiple compared to <strong>Advanced Micro Devices Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) and Nvidia.</p>
<p><em>Read Next: <a href="https://www.benzinga.com/news/earnings/earnings-beats/24/04/38467013/tech-stocks-rebound-as-magnificent-7-roar-on-strong-earnings-energy-giants-tumble-wh">Tech Stocks Rebound As Magnificent 7 Roar On Strong Earnings, Energy Giants Tumble: What&#8217;s Driving Markets Friday?</a></em></p>
<p><em>Image: Shutterstock</em></p>


Analyst Color

Earnings

Tech

INTC

NVDA

Intel 'Still A Work In Progress' As 'Turnaround Efforts Take Root,' Analysts Say After Q1 Disappointment

<p><strong>Optimism's</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">OP</a>) price has decreased 4.11% over the past 24 hours to <strong>$2.35</strong>. This is contrary to the coins performance over the past week where it has experienced an up-trend of 3.0%, moving from $2.28 to its current price.</p>
<p>The chart below compares the price movement and volatility for Optimism over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714158155_0.png" alt="price_chart" /></p>
<p>The trading volume for the coin has decreased 22.0% over the past week, while the overall circulating supply of the coin has increased 0.25% to over 1.05 billion. This puts its current circulating supply at an estimated 24.34% of its max supply, which is 4.29 billion. The current market cap ranking for OP is #50 at $2.46 billion.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714158155_1.png" alt="supply_and_vol" /></p>
<p><a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Cryptocurrency Optimism Decreases More Than 4% Within 24 hours

<p><strong>The Graph's</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">GRT</a>) price has decreased 4.14% over the past 24 hours to <strong>$0.26</strong>, continuing its downward trend over the past week of -0.0%, moving from $0.26 to its current price. </p>
<p>The chart below compares the price movement and volatility for The Graph over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714158145_0.png" alt="price_chart" /></p>
<p>The trading volume for the coin has fallen 35.0% over the past week which is opposite, directionally, with the overall circulating supply of the coin, which has increased 0.19%. This brings the circulating supply to 9.48 billion, which makes up an estimated 87.9% of its max supply of 10.79 billion. According to our data, the current market cap ranking for GRT is #49 at $2.46 billion.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714158145_1.png" alt="supply_and_vol" /></p>
<p><a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Golden Ratio Token - United States Dollar

$GRT

Cryptocurrency The Graph Down More Than 4% Within 24 hours

<p>Over the past 24 hours, <strong>Maker's</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/mkr/usd">MKR</a>) price has risen 3.07% to <strong>$2,944.05</strong>. This is contrary to its negative trend over the past week where it has experienced a 2.0% loss, moving from $2,958.16 to its current price. As it stands right now, <strong>the coin's all-time high is $6,292.31</strong>. </p>
<p>The chart below compares the price movement and volatility for Maker over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714158075_0.png" alt="price_chart" /></p>
<p>The trading volume for the coin has decreased 34.0% over the past week, while the overall circulating supply of the coin has decreased 0.1% to over 925 thousand. This puts its current circulating supply at an estimated 92.0% of its max supply, which is 1.01 million. The current market cap ranking for MKR is #47 at $2.72 billion.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714158075_1.png" alt="supply_and_vol" /></p>
<p><a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


$MKR

Cryptocurrency Maker Rises More Than 3% In 24 hours

<p>In the latest quarter, 5 analysts provided ratings for Newmont (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>), showcasing a mix of bullish and bearish perspectives.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>In the assessment of 12-month price targets, analysts unveil insights for Newmont, presenting an average target of $46.5, a high estimate of $56.00, and a low estimate of $40.00. A decline of 8.82% from the prior average price target is evident in the current average. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714158068_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>The analysis of recent analyst actions sheds light on the perception of Newmont by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Greg Barnes</td>
<td>TD Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$48.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Alexander Hacking</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$45.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Tanya Jakusconek</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$43.50</td>
<td>$50.00</td>
</tr>
<tr>
<td>Jackie Przybylowski</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$56.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Josh Wolfson</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$40.00</td>
<td>$45.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Newmont. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Newmont compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts predict movements in price targets, offering estimates for Newmont's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Newmont's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/NEM/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Newmont analyst ratings.</strong></a></p>
<h2>About Newmont</h2>
<p>Newmont is the world's largest gold miner. It bought Goldcorp in 2019, combined its Nevada mines in a joint venture with competitor Barrick later that year, and also purchased competitor Newcrest in November 2023. Its portfolio includes 17 wholly or majority owned mines and interests in two joint ventures in the Americas, Africa, Australia and Papua New Guinea. The company is expected to produce roughly 6.9 million ounces of gold in 2024. However, after buying Newcrest, Newmont is likely to sell a number of its higher cost, smaller mines accounting for 20% of forecast sales in 2024. Newmont also produces material amounts of copper, silver, zinc, and lead as byproducts. It had about two decades of gold reserves along with significant byproduct reserves at end December 2023.</p>
<h3>A Deep Dive into Newmont's Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Newmont's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>23.66%</strong> as of 31 December, 2023, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.</p>
<p><strong>Net Margin:</strong> Newmont's net margin excels beyond industry benchmarks, reaching <strong>-79.81%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Newmont's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of <strong>-13.13%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Return on Assets (ROA):</strong> Newmont's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>-6.75%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> Newmont's debt-to-equity ratio surpasses industry norms, standing at <strong>0.33</strong>. This suggests the company carries a substantial amount of debt, posing potential financial challenges.</p>
<h2>Analyst Ratings: What Are They?</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


What 5 Analyst Ratings Have To Say About Newmont

<p>In the latest quarter, 5 analysts provided ratings for Laboratory Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LH#NYSE">LH</a>), showcasing a mix of bullish and bearish perspectives.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets, analyzed by analysts, offer insights with an average target of $242.4, a high estimate of $260.00, and a low estimate of $213.00. Experiencing a 4.19% decline, the current average is now lower than the previous average price target of $253.00. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714158054_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>The standing of Laboratory Corp among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ryan MacDonald</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$255.00</td>
<td>$270.00</td>
</tr>
<tr>
<td>Stephanie Davis</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$213.00</td>
<td>$234.00</td>
</tr>
<tr>
<td>Eric Coldwell</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$244.00</td>
<td>$255.00</td>
</tr>
<tr>
<td>Michael Cherny</td>
<td>Leerink Partners</td>
<td>Announces</td>
<td>Outperform</td>
<td>$260.00</td>
<td>-</td>
</tr>
<tr>
<td>Elizabeth Anderson</td>
<td>Evercore ISI Group</td>
<td>Announces</td>
<td>In-Line</td>
<td>$240.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Laboratory Corp. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Laboratory Corp compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts gauge the dynamics of price targets, providing estimates for the future value of Laboratory Corp's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Laboratory Corp's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/LH/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Laboratory Corp analyst ratings.</strong></a></p>
<h2>Get to Know Laboratory Corp Better</h2>
<p>Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.</p>
<h3>Key Indicators: Laboratory Corp's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.</p>
<p><strong>Revenue Growth:</strong> Laboratory Corp's remarkable performance in 3 months is evident. As of 31 December, 2023, the company achieved an impressive revenue growth rate of <strong>3.54%</strong>. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of <strong>-5.51%,</strong> the company may need to address challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Laboratory Corp's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>-2.12%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Laboratory Corp's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>-0.99%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> Laboratory Corp's debt-to-equity ratio is below the industry average. With a ratio of <b>0.76</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Laboratory Corporation Of America Holdings

Analyst Ratings For Laboratory Corp

<p>Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Compass Minerals Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMP#NYSE">CMP</a>) in the last three months.</p>
<p>The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $22.5, a high estimate of $26.00, and a low estimate of $20.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 13.46%. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714158045_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Compass Minerals Intl. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Chris Kapsch</td>
<td>Loop Capital</td>
<td>Lowers</td>
<td>Buy</td>
<td>$23.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Joel Jackson</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$20.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Chris Kapsch</td>
<td>Loop Capital</td>
<td>Lowers</td>
<td>Hold</td>
<td>$26.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$21.00</td>
<td>$24.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Compass Minerals Intl. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Compass Minerals Intl compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Compass Minerals Intl's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Capture valuable insights into Compass Minerals Intl's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/CMP/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Compass Minerals Intl analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>Discovering Compass Minerals Intl: A Closer Look</h2>
<p>Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Canada, the us state of Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.</p>
<h3>Compass Minerals Intl: A Financial Overview</h3>
<p><strong>Market Capitalization Analysis:</strong> The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Compass Minerals Intl's financials over 3 months reveals challenges. As of 31 December, 2023, the company experienced a decline of approximately <strong>-3.04%</strong> in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.</p>
<p><strong>Net Margin:</strong> Compass Minerals Intl's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>-22.04%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Compass Minerals Intl's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>-15.41%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Compass Minerals Intl's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>-4.16%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of <strong>1.99</strong>, caution is advised due to increased financial risk.</p>
<h2>Analyst Ratings: What Are They?</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Ratings For Compass Minerals Intl

<p>Throughout the last three months, 9 analysts have evaluated Churchill Downs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHDN#NASDAQ">CHDN</a>), offering a diverse set of opinions from bullish to bearish.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $145.67, a high estimate of $153.00, and a low estimate of $137.00. This upward trend is evident, with the current average reflecting a 1.58% increase from the previous average price target of $143.40.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714158037_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>A clear picture of Churchill Downs's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Barry Jonas</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$145.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Jeffrey Stantial</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$153.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Ben Chaiken</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Buy</td>
<td>$143.00</td>
<td>$142.00</td>
</tr>
<tr>
<td>Daniel Politzer</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$141.00</td>
<td>$137.00</td>
</tr>
<tr>
<td>Jordan Bender</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$150.00</td>
<td>-</td>
</tr>
<tr>
<td>Daniel Politzer</td>
<td>Wells Fargo</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$137.00</td>
<td>-</td>
</tr>
<tr>
<td>Ben Chaiken</td>
<td>Mizuho</td>
<td>Announces</td>
<td>Buy</td>
<td>$142.00</td>
<td>-</td>
</tr>
<tr>
<td>Jordan Bender</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$150.00</td>
<td>-</td>
</tr>
<tr>
<td>Jordan Bender</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$150.00</td>
<td>$148.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Churchill Downs. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Churchill Downs compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts gauge the dynamics of price targets, providing estimates for the future value of Churchill Downs's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>For valuable insights into Churchill Downs's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/CHDN/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Churchill Downs analyst ratings.</strong></a></p>
<h2>Unveiling the Story Behind Churchill Downs</h2>
<p>Churchill Downs Inc is a gaming entertainment, online wagering, and racing company. It operates through three business segments: Live and Historical Racing, TwinSpires, and Gaming. The Live and Historical Racing segment includes live and historical pari-mutuel racing. The TwinSpires segment includes the revenue and expenses for online horse racing and the online and retail sports betting and iGaming wagering business. The Gaming segment includes revenue and expenses for the casino properties and associated racetracks that support the casino license. The Gaming segment generates revenue and expenses from slot machines, table games, video lottery terminals, video poker, HRMs, ancillary food and beverage services, hotel services, commission on pari-mutuel wagering, and racing events.</p>
<h3>Churchill Downs's Financial Performance</h3>
<p><strong>Market Capitalization Highlights:</strong> Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.</p>
<p><strong>Revenue Growth:</strong> Churchill Downs's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2024, the company achieved a revenue growth rate of approximately <strong>5.61%</strong>. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> Churchill Downs's net margin excels beyond industry benchmarks, reaching <strong>13.61%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Churchill Downs's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>9.35%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Churchill Downs's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>1.15%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of <strong>5.96</strong>, caution is advised due to increased financial risk.</p>
<h2>Analyst Ratings: What Are They?</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


CHDN

A Glimpse Into The Expert Outlook On Churchill Downs Through 9 Analysts

<p>Cintas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTAS#NASDAQ">CTAS</a>) has outperformed the market over the past 15 years by 12.05% on an annualized basis producing an average annual return of 24.22%. Currently, Cintas has a market capitalization of $67.50 billion. </p>
<p><strong>Buying $1000 In CTAS:</strong> If an investor had bought $1000 of CTAS stock 15 years ago, it would be worth <strong>$25,941.17</strong> today based on a price of $665.25 for CTAS at the time of writing.</p>
<h3>Cintas's Performance Over Last 15 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714158029_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


CTAS

Here's How Much $1000 Invested In Cintas 15 Years Ago Would Be Worth Today

<p>During the last three months, 7 analysts shared their evaluations of Steven Madden (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHOO#NASDAQ">SHOO</a>), revealing diverse outlooks from bullish to bearish.</p>
<p>The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets, analyzed by analysts, offer insights with an average target of $42.0, a high estimate of $45.00, and a low estimate of $38.00. This upward trend is evident, with the current average reflecting a 4.14% increase from the previous average price target of $40.33.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714158027_0.png" alt="price target chart" /></p>
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>The perception of Steven Madden by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$44.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>Paul Lejuez</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$43.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Sam Poser</td>
<td>Williams Trading</td>
<td>Announces</td>
<td>Hold</td>
<td>$44.00</td>
<td>-</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$39.00</td>
<td>-</td>
</tr>
<tr>
<td>Abbie Zvejnieks</td>
<td>Piper Sandler</td>
<td>Announces</td>
<td>Neutral</td>
<td>$45.00</td>
<td>-</td>
</tr>
<tr>
<td>Tom Nikic</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Neutral</td>
<td>$38.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Paul Lejuez</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Neutral</td>
<td>$41.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Steven Madden. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Steven Madden compared to the broader market.</li>
<li><strong>Price Targets:</strong> Understanding forecasts, analysts offer estimates for Steven Madden's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
<p>To gain a panoramic view of Steven Madden's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/SHOO/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Steven Madden analyst ratings.</strong></a></p>
<h2>About Steven Madden</h2>
<p>Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its own stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.</p>
<h3>Breaking Down Steven Madden's Financial Performance</h3>
<p><strong>Market Capitalization:</strong> With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Steven Madden showcased positive performance, achieving a revenue growth rate of <strong>10.43%</strong> as of 31 December, 2023. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Steven Madden's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>6.9%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Steven Madden's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>4.31%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Steven Madden's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>2.72%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> Steven Madden's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.17</strong>.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


SHOO

Analyst Ratings For Steven Madden

<p><strong>AGBA Group Holding's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGBA#NYSE">AGBA</a>) short percent of float has risen 200.0% since its last report. The company recently reported that it has <strong>97 thousand shares sold short</strong>, which is 0.54% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 1.0 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest"><strong>List of the most shorted stocks</strong></a></p>
<h3>AGBA Group Holding Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714158027_0_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for AGBA Group Holding has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing AGBA Group Holding's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, AGBA Group Holding's peer group average for short interest as a percentage of float is 5.52%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Short Ideas

AGBA

(AGBA) - Analyzing AGBA Group Holding's Short Interest

<p>Booking Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>) has outperformed the market over the past 20 years by 20.1% on an annualized basis producing an average annual return of 27.96%. Currently, Booking Holdings has a market capitalization of $119.15 billion. </p>
<p><strong>Buying $1000 In BKNG:</strong> If an investor had bought $1000 of BKNG stock 20 years ago, it would be worth <strong>$141,578.21</strong> today based on a price of $3502.48 for BKNG at the time of writing.</p>
<h3>Booking Holdings's Performance Over Last 20 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714158023_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


BKNG

Here's How Much $1000 Invested In Booking Holdings 20 Years Ago Would Be Worth Today

<p><strong>Biglari Holdings's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BH#NYSE">BH</a>) short percent of float has fallen 12.66% since its last report. The company recently reported that it has <strong>6 thousand shares sold short</strong>, which is 0.69% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 2.09 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest"><strong>List of the most shorted stocks</strong></a></p>
<h3>Biglari Holdings Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714158022_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Biglari Holdings has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.</p>
<h3>Comparing Biglari Holdings's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Biglari Holdings's peer group average for short interest as a percentage of float is 10.48%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Looking Into Biglari Holdings's Recent Short Interest

<p>12 analysts have shared their evaluations of Southwest Airlines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts have set 12-month price targets for Southwest Airlines, revealing an average target of $31.75, a high estimate of $42.00, and a low estimate of $25.00. This upward trend is evident, with the current average reflecting a 6.9% increase from the previous average price target of $29.70.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714158019_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>A clear picture of Southwest Airlines's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Helane Becker</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Hold</td>
<td>$25.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Savanthi Syth</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$30.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Brandon Oglenski</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$26.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Christopher Stathoulopoulos</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$27.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Ravi Shanker</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$38.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Brandon Oglenski</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$30.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Atul Maheswari</td>
<td>UBS</td>
<td>Announces</td>
<td>Buy</td>
<td>$36.00</td>
<td>-</td>
</tr>
<tr>
<td>David Vernon</td>
<td>Bernstein</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$27.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Sheila Kahyaoglu</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$28.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>John Staszak</td>
<td>Argus Research</td>
<td>Announces</td>
<td>Buy</td>
<td>$40.00</td>
<td>-</td>
</tr>
<tr>
<td>Michael Linenberg</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$42.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>David Vernon</td>
<td>Bernstein</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$32.00</td>
<td>$26.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Southwest Airlines. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Southwest Airlines compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts predict movements in price targets, offering estimates for Southwest Airlines's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Southwest Airlines's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/LUV/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Southwest Airlines analyst ratings.</strong></a></p>
<h2>All You Need to Know About Southwest Airlines</h2>
<p>Southwest Airlines is the largest domestic air carrier in the United States by passengers boarded. Southwest operates over 700 aircraft in an all-Boeing 737 fleet. Despite offering some longer routes and a few perks for business travelers, the airline predominantly specializes in short-haul, leisure flights, using a point-to-point network. Southwest operates a low-cost carrier business model.</p>
<h3>Key Indicators: Southwest Airlines's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.</p>
<p><strong>Revenue Growth:</strong> Southwest Airlines's remarkable performance in 3 months is evident. As of 31 December, 2023, the company achieved an impressive revenue growth rate of <strong>10.55%</strong>. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Southwest Airlines's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>-3.41%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Southwest Airlines's ROE excels beyond industry benchmarks, reaching <strong>-2.16%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>-0.63%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.87</strong>.</p>
<h2>Analyst Ratings: Simplified</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Where Southwest Airlines Stands With Analysts

Equillium GAAP EPS of -$0.07, revenue of $9.2M

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Equillium</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/eq-stock-quote/"><strong>EQ</strong></a></span>) just reported results for the fourth quarter of 2023.</p><ul><li>Equillium reported earnings per share of -7 cents. This was above the analyst estimate for EPS of -17 cents.</li><li>The company reported revenue of $9.21 million.</li><li>This was 4.08% better than the analyst estimate for revenue of $8.85 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/03/eq-stock-earnings-equillium-for-q4-of-2023/">EQ Stock Earnings: Equillium Beats EPS, Beats Revenue for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

EQ Stock Earnings: Equillium Beats EPS, Beats Revenue for Q4 2023

VERI, CHEK and CZOO among mid-day movers

Tuesday, March 26, 2024 - Equillium Inc (EQ) reported upside earnings and revenues today.Analyst expectations for Equillium Inc earnings per share (EPS) were at a loss of $0.17 per share, with the company surpassing those estimates with a reported EPS loss of $0.07 per share, leading to a positive surprise of $0.1 per shar

Equillium Inc Down 19.47% To $1.97 After Earnings Beat

These Healthcare stocks are trading higher:-Stoke Therapeutics Inc (STOK) stock is trading at $10.98, an increase of $4.48, or 70%, on high volume.  Stoke Therapeutics Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $19.86.  -N

Healthcare Stocks Moving Up and Down Tuesday: STOK, NUVB, RVPH, CRDL, EQ, PRE, BLRX, GLUE

In a report released on March 25, Thomas Smith from Leerink Partners reiterated a Buy rating on Equillium (EQ – Research Report), with a price targ...